Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee, 43147-43148 [E9-20487]
Download as PDF
jlentini on DSKJ8SOYB1PROD with NOTICES
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices
Sanitation Facilities Construction, Two
Renaissance Square, Suite 720, 40 North
Central Avenue, Phoenix, Arizona
85004–4424.
Director, Elko Field Office IHS;
Attention: Sanitation Facilities
Construction, 557 W. Silver Street, Suite
204, Elko, Nevada 89801.
Director, Fort Duchesne Indian Health
Center; Attention: Sanitation Facilities
Construction, P.O. Box 489, Fort
Duchesne, Utah 84026.
Director, Eastern Arizona District
Office IHS; Attention: Sanitation
Facilities Construction, 5448 S. White
Mountain Road, Suite 220, Lakeside,
Arizona 85929.
Director, Hopi Health Care Center;
Attention: Sanitation Facilities
Construction, P.O. Box 4000, Polacca,
Arizona 86042
Director, San Carlos PHS Indian
Hospital; Attention: Sanitation Facilities
Construction, P.O. Box 208, San Carlos,
Arizona 85550.
Director, Reno District Office IHS;
Attention: Sanitation Facilities
Construction, 1395 Greg Street, Suite
101, Sparks, Nevada 89431.
Director, Western Arizona District
Office IHS; Attention: Sanitation
Facilities Construction, 1553 West Todd
Drive, Suite 107, Tempe, Arizona 85283.
Director, Whiteriver PHS Indian
Hospital; Attention: Sanitation Facilities
Construction, P.O. Box 860, Whiteriver,
Arizona 85941.
Director, Fort Yuma PHS Indian
Hospital; Attention: Sanitation Facilities
Construction, P.O. Box 1368, Yuma,
Arizona 85364.
Director, Portland Area IHS;
Attention: Director, Division of
Sanitation Facilities Construction, 1220
SW. Third Avenue, Room 476, Portland,
Oregon 97204.
Director, Olympic District Office IHS;
Attention: Sanitation Facilities
Construction, 4060 Wheaton Way, Suite
B, Bremerton, Washington 98310.
Director, Fort Hall Field Office IHS;
Attention: Sanitation Facilities
Construction, P.O. Box 717, Mission
Road, Fort Hall, Idaho 83203.
Director, Port Angeles Field Office
IHS; Attention: Sanitation Facilities
Construction, 1601 East Front Street,
Building B, Suite C, Port Angeles,
Washington 98362.
Director, Western Oregon Service Unit
IHS; Attention: Sanitation Facilities
Construction, 3750 Chemawa Road, NE.,
Salem, Oregon 97305.
Director, Seattle District Office IHS;
Attention: Sanitation Facilities
Construction, 2201 Sixth Avenue, Room
300, Seattle, Washington 98121.
Director, Spokane District Office IHS;
Attention: Sanitation Facilities
VerDate Nov<24>2008
17:05 Aug 25, 2009
Jkt 217001
Construction, 1919 E. Francis Avenue,
Spokane, Washington 99208.
Director, Tucson Area IHS; Attention:
Director, Division of Sanitation
Facilities Construction, 7900 S.J. Stock
Road, Tucson, Arizona 85746–7012.
Director, Western District Office IHS;
Attention: Sanitation Facilities
Construction, 2250 North Final Avenue,
Suite 4, Casa Grande, Arizona 85222.
Director, Sells Service Unit IHS;
Attention: Sanitation Facilities
Construction, P.O. Box 548, Mesquite
Street, Sells, Arizona 85634.
[FR Doc. E9–20410 Filed 8–25–09; 8:45 am]
BILLING CODE 4160–16–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0394]
Request for Nominations for Voting
Members on a Public Advisory
Committee; Tobacco Products
Scientific Advisory Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is requesting
nominations for members to serve on
the Tobacco Products Scientific
Advisory Committee (the committee) in
the Office of Science, Center for
Tobacco Products. Elsewhere in this
issue of the Federal Register, FDA is
publishing a document announcing the
establishment of this committee.
FDA has a special interest in ensuring
that women, minority groups, and
individuals with disabilities are
adequately represented on advisory
committees and, therefore, encourages
nominations of qualified candidates
from these groups.
DATES: Nominations received on or
before October 13, 2009, will be given
first consideration for membership on
the Tobacco Products Scientific
Advisory Committee. Nominations
received after October 13, 2009, will be
considered for nomination to the
Tobacco Products Scientific Advisory
Committee should nominees still be
needed.
All letters of interest and
nominations should be submitted in
writing to Erik P. Mettler (see FOR
FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Erik
P. Mettler, Office of Policy, Office of the
Commissioner, Food and Drug
Administration, 10903 New Hampshire
ADDRESSES:
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
43147
Ave., WO1, rm. 4324, Silver Spring, MD
20993, 301–796–4711, FAX: 301–847–
3541, e-mail: erik.mettler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: FDA is
requesting nominations for voting
members on the Tobacco Products
Scientific Advisory Committee.
Elsewhere in this issue of the Federal
Register, FDA is publishing a Request
for Notification from Industry
Organizations interested in participating
in the selection process for nonvoting
industry representatives on the Tobacco
Products Scientific Advisory
Committee.
I. Function of the Tobacco Products
Scientific Advisory Committee
The Tobacco Products Scientific
Advisory Committee advises the
Commissioner of Food and Drugs (the
Commissioner) or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information, and
recommendations to the Commissioner.
II. Criteria for Voting Members
The committee shall consist of 12
members including the Chair. Members
and the Chair are selected by the
Commissioner or designee from among
individuals knowledgeable in the fields
of medicine, medical ethics, science, or
technology involving the manufacture,
evaluation, or use of tobacco products.
Almost all non-Federal members of this
committee serve as Special Government
Employees. The committee shall
include nine technically qualified
voting members, selected by the
Commissioner or designee. The nine
voting members shall be physicians,
dentists, scientists, or health care
professionals practicing in the area of
oncology, pulmonology, cardiology,
toxicology, pharmacology, addiction, or
any other relevant specialty. One
member shall be an officer or employee
of a State or local government or of the
Federal Government. The final voting
member shall be a representative of the
general public.
In addition to the voting members, the
committee shall include three nonvoting
members who are identified with
industry interests. These members shall
include one representative of the
tobacco manufacturing industry, one
representative of the interests of tobacco
growers, and one representative of the
interests of the small business tobacco
manufacturing industry. This final
position can be filled on a rotating,
sequential basis by representatives of
E:\FR\FM\26AUN1.SGM
26AUN1
43148
Federal Register / Vol. 74, No. 164 / Wednesday, August 26, 2009 / Notices
different small business tobacco
manufacturers based on areas of
expertise relevant to the topics being
considered by the committee. Elsewhere
in this issue of the Federal Register,
FDA is publishing a Request for
Notification from Industry
Organizations interested in participating
in the selection process for nonvoting
industry representatives on the Tobacco
Products Scientific Advisory
Committee.
The Commissioner or designee shall
designate one of the voting members of
the committee to serve as chairperson.
III. Nomination Procedures
Any interested person may nominate
one or more qualified persons for
membership on the advisory committee.
Self-nominations are also accepted.
Nominations must include a current
resume or curriculum vitae of each
nominee, including current business
address and/or home address, telephone
number, and e-mail address if available.
Nominations must also acknowledge
that the nominee is aware of the
nomination unless self-nominated. FDA
will ask the potential candidates to
provide detailed information concerning
matters related to financial holdings,
employment, and research grants and/or
contracts.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: August 19, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9–20487 Filed 8–25–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[USCG–2009–0737]
Great Lakes Pilotage Advisory
Committee
Coast Guard, DHS.
Notice of meeting; request for
applications.
AGENCY:
jlentini on DSKJ8SOYB1PROD with NOTICES
ACTION:
SUMMARY: The Coast Guard announces
the Great Lakes Pilotage Advisory
Committee (GLPAC) 2009 annual
meeting and seeks applications to fill
one vacancy on the GLPAC. GLPAC
provides advice and recommendations
to the Secretary on issues related to
pilotage on the Great Lakes. GLPAC’s
meeting will be open to the public.
VerDate Nov<24>2008
17:05 Aug 25, 2009
Jkt 217001
DATES: GLPAC will meet on Monday,
September 21, 2009, from 10 a.m. to 2
p.m. The meeting may close early if all
business is finished. Written material
and requests to make oral presentations
or to have a copy of your material
distributed to each member of the
committee should reach us on or before
September 14, 2009. Applications for
GLPAC membership should reach us by
October 2, 2009.
ADDRESSES: GLPAC will meet at Coast
Guard Headquarters, 2100 2nd Street,
SW., Washington, DC 20593–0001,
Room 6303. Send written material and
requests relating to the GLPAC meeting
to Mr. John Bobb (see FOR FURTHER
INFORMATION CONTACT). Electronically
submitted material must be in Adobe or
Microsoft Word format. Also, send
applications for GLPAC membership to
Mr. Bobb. An application form for
GLPAC membership, as well as this
notice, is available in our online docket,
USCG–2009–0737, at https://
www.regulations.gov; enter the docket
number for this notice (USCG–2009–
0737) in the Search box, and click ‘‘Go.’’
You may also contact Mr. Bobb for a
copy of the application form.
FOR FURTHER INFORMATION CONTACT: Mr.
John Bobb, GLPAC Assistant Designated
Federal Official (ADFO), Commandant
(CG–54121), U.S. Coast Guard
Headquarters, 2100 Second Street, SW.,
Stop 7581, Washington, DC 20593–
7581; telephone 202–372–1532, fax
202–372–1929, or e-mail at
john.k.bobb@uscg.mil.
SUPPLEMENTARY INFORMATION: The
GLPAC is a Federal advisory committee
under 5 U.S.C. App. 2 (Pub. L. 92–463).
It was established under the authority of
46 U.S.C. 9307, and advises the
Secretary of Homeland Security and the
Coast Guard on Great Lakes pilot
registration, operating requirements,
training policies, and pilotage rates.
GLPAC meets at least once a year,
normally at Coast Guard Headquarters,
Washington, DC. It may also meet for
extraordinary purposes. Further
information about GLPAC is available
by searching on ‘‘Great Lakes Pilotage
Advisory Committee’’ at https://
www.fido.gov/facadatabase/.
Notice of Meeting
GLPAC’s 2009 annual meeting will be
held at Coast Guard Headquarters on
September 21, 2009.
The agenda includes the following:
(1) GLPAC review of public comments
solicited by the Coast Guard in the
Federal Register of July 21, 2009 (‘‘Great
Lakes Pilotage Ratemaking
Methodology,’’ 74 FR 35838), in
accordance with requirements of 46
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
U.S.C. 9307(d) for consultation with
GLPAC before taking any significant
action relating to Great Lakes pilotage;
(2) Appointment of seventh member
in compliance with requirements of 46
U.S.C. 9307(b)(2)(E);
(3) Election of chairman and vice
chairman in compliance with
requirements of 46 U.S.C. 9307(c)(1);
(4) GLPAC recommendation to
Congress whether GLPAC be renewed
and continued beyond its current
termination date of September 30, 2010
in compliance with requirements of 46
U.S.C. 9307(f)(2).
(5) Report from the Director of Great
Lakes Pilotage.
The meeting is open to the public.
Please note that the meeting may close
early if all business is finished. At the
Chair’s discretion, members of the
public may make oral presentations
during the meeting. For information on
facilities or services for individuals with
disabilities or to request special
assistance at the meeting, contact Mr.
John Bobb (see FOR FURTHER
INFORMATION CONTACT) as soon as
possible.
Request for Applications
We will consider applications to fill
one vacancy on the committee. To be
eligible, candidates must have a
background in finance or accounting.
The person selected must be
recommended to the Secretary by
unanimous vote of GLPAC’s other
members, and may be appointed
without regard to the requirement that
each member have five years of practical
experience in maritime operations. The
person selected may, but need not, come
from among those who respond to this
request for applications. The person
selected will serve for a term of three
years, which may be renewed once.
Members serve at their own expense
and receive no salary but may be
reimbursed for travel expenses.
In support of the Coast Guard policy
on gender and ethnic
nondiscrimination, we encourage
qualified men and women and members
of all racial and ethnic groups to apply.
The Coast Guard values diversity; all the
different characteristics and attributes of
persons that enhance the mission of the
Coast Guard.
The person selected to fill this
vacancy will be appointed and serve as
a Special Government Employee (SGE)
as defined in section 202 (a) of title 18,
United States Code. As a candidate for
appointment as SGE, applicants are
required to complete a Confidential
Financial Disclosure Report (OGE Form
450). A completed OGE Form 450 is not
releasable to the public except under an
E:\FR\FM\26AUN1.SGM
26AUN1
Agencies
[Federal Register Volume 74, Number 164 (Wednesday, August 26, 2009)]
[Notices]
[Pages 43147-43148]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0394]
Request for Nominations for Voting Members on a Public Advisory
Committee; Tobacco Products Scientific Advisory Committee
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is requesting
nominations for members to serve on the Tobacco Products Scientific
Advisory Committee (the committee) in the Office of Science, Center for
Tobacco Products. Elsewhere in this issue of the Federal Register, FDA
is publishing a document announcing the establishment of this
committee.
FDA has a special interest in ensuring that women, minority groups,
and individuals with disabilities are adequately represented on
advisory committees and, therefore, encourages nominations of qualified
candidates from these groups.
DATES: Nominations received on or before October 13, 2009, will be
given first consideration for membership on the Tobacco Products
Scientific Advisory Committee. Nominations received after October 13,
2009, will be considered for nomination to the Tobacco Products
Scientific Advisory Committee should nominees still be needed.
ADDRESSES: All letters of interest and nominations should be submitted
in writing to Erik P. Mettler (see FOR FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT: Erik P. Mettler, Office of Policy,
Office of the Commissioner, Food and Drug Administration, 10903 New
Hampshire Ave., WO1, rm. 4324, Silver Spring, MD 20993, 301-796-4711,
FAX: 301-847-3541, e-mail: erik.mettler@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: FDA is requesting nominations for voting
members on the Tobacco Products Scientific Advisory Committee.
Elsewhere in this issue of the Federal Register, FDA is publishing a
Request for Notification from Industry Organizations interested in
participating in the selection process for nonvoting industry
representatives on the Tobacco Products Scientific Advisory Committee.
I. Function of the Tobacco Products Scientific Advisory Committee
The Tobacco Products Scientific Advisory Committee advises the
Commissioner of Food and Drugs (the Commissioner) or designee in
discharging responsibilities as they relate to the regulation of
tobacco products. The committee reviews and evaluates safety,
dependence, and health issues relating to tobacco products and provides
appropriate advice, information, and recommendations to the
Commissioner.
II. Criteria for Voting Members
The committee shall consist of 12 members including the Chair.
Members and the Chair are selected by the Commissioner or designee from
among individuals knowledgeable in the fields of medicine, medical
ethics, science, or technology involving the manufacture, evaluation,
or use of tobacco products. Almost all non-Federal members of this
committee serve as Special Government Employees. The committee shall
include nine technically qualified voting members, selected by the
Commissioner or designee. The nine voting members shall be physicians,
dentists, scientists, or health care professionals practicing in the
area of oncology, pulmonology, cardiology, toxicology, pharmacology,
addiction, or any other relevant specialty. One member shall be an
officer or employee of a State or local government or of the Federal
Government. The final voting member shall be a representative of the
general public.
In addition to the voting members, the committee shall include
three nonvoting members who are identified with industry interests.
These members shall include one representative of the tobacco
manufacturing industry, one representative of the interests of tobacco
growers, and one representative of the interests of the small business
tobacco manufacturing industry. This final position can be filled on a
rotating, sequential basis by representatives of
[[Page 43148]]
different small business tobacco manufacturers based on areas of
expertise relevant to the topics being considered by the committee.
Elsewhere in this issue of the Federal Register, FDA is publishing a
Request for Notification from Industry Organizations interested in
participating in the selection process for nonvoting industry
representatives on the Tobacco Products Scientific Advisory Committee.
The Commissioner or designee shall designate one of the voting
members of the committee to serve as chairperson.
III. Nomination Procedures
Any interested person may nominate one or more qualified persons
for membership on the advisory committee. Self-nominations are also
accepted. Nominations must include a current resume or curriculum vitae
of each nominee, including current business address and/or home
address, telephone number, and e-mail address if available. Nominations
must also acknowledge that the nominee is aware of the nomination
unless self-nominated. FDA will ask the potential candidates to provide
detailed information concerning matters related to financial holdings,
employment, and research grants and/or contracts.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.
Dated: August 19, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-20487 Filed 8-25-09; 8:45 am]
BILLING CODE 4160-01-S